Filed: Apr. 24, 2012
Latest Update: Apr. 24, 2012
Summary: MEMORANDUM DECISION AND ORDER DENYING PLAINTIFFS' MOTION TO QUASH BROOKE WELLS, Magistrate Judge. Before the Court is Plaintiffs Brigham Young University and Dr. Daniel Simmons (collectively "BYU") Motion to Quash. 1 BYU moves to quash the Defendants Pfizer, Inc., G.D. Searle & Company, G.D. Searle LLC, Monsanto Company, and Pharmacia Corporation's (collectively "Pfizer") (1) Subpoena to Testify at a Deposition in a Civil Action; and (2) Subpoena to Produce Documents, Information, or Objects
Summary: MEMORANDUM DECISION AND ORDER DENYING PLAINTIFFS' MOTION TO QUASH BROOKE WELLS, Magistrate Judge. Before the Court is Plaintiffs Brigham Young University and Dr. Daniel Simmons (collectively "BYU") Motion to Quash. 1 BYU moves to quash the Defendants Pfizer, Inc., G.D. Searle & Company, G.D. Searle LLC, Monsanto Company, and Pharmacia Corporation's (collectively "Pfizer") (1) Subpoena to Testify at a Deposition in a Civil Action; and (2) Subpoena to Produce Documents, Information, or Objects ..
More
MEMORANDUM DECISION AND ORDER DENYING PLAINTIFFS' MOTION TO QUASH
BROOKE WELLS, Magistrate Judge.
Before the Court is Plaintiffs Brigham Young University and Dr. Daniel Simmons (collectively "BYU") Motion to Quash.1 BYU moves to quash
the Defendants Pfizer, Inc., G.D. Searle & Company, G.D. Searle LLC, Monsanto Company, and Pharmacia Corporation's (collectively "Pfizer") (1) Subpoena to Testify at a Deposition in a Civil Action; and (2) Subpoena to Produce Documents, Information, or Objects or to Permit Inspection of Premises in a Civil Action served on third-party DNA Solutions, Inc. ("DNA Solutions"), an Oklahoma corporation.2
Previously this Court denied BYU's motion.3 BYU then filed a Motion for Reconsideration arguing that it did not receive notice of Pfizer's opposition memorandum and thus did not have a chance to respond to Pfizer's arguments.4 A reply memorandum is discretionary and unnecessary for the Court to rule on a motion.5 But, due to concerns with proper service the Court granted BYU's motion and permitted Plaintiffs to file a reply.6 BYU filed its reply on April 20, 2012.7
In its reply BYU asserts that Pfizer mischaracterizes the facts relating to the DNA Solutions expert reports. BYU argues that contrary to Pfizer's allegations, the reports do not support Pfizer's position that BYU's mouse COX-2 clones did not work. In essence BYU devotes the majority of its reply memorandum to arguments concerning the merits of the underlying case. These arguments, however, are not helpful to the Court in deciding the instant motion because in its prior decision the Court did not consider the underlying merits of the case in reaching its decision. Rather, the Court rejected BYU's assertion that this case was analogous to Callaway Golf Co. v. Dunlop Slazenger Group Americas, Inc.8 and declined to apply the exceptional circumstances test. Instead the Court applied a balancing test and found that withdrawing a designation of an expert this late in a case, after that expert had filed a report, an amended report and a supplemental report was prejudicial to Pfizer.9 BYU makes no additional arguments in its reply that persuade the Court to alter its prior decision. Moreover, after a de novo review of the arguments of counsel and the facts of this case, even if this Court were to adopt an exceptional circumstances approach, the Court would still deny BYU's motion. To withdraw an expert at such a late stage in this case after they have filed not one, but in essence three reports,10 creates an exceptional circumstance warranting the opposing party being able to rely on that expert designation.
Finally, in its reply BYU asks in the alternative that it (1) "be allotted equal time to ask questions at the depositions; and (2) that BYU be able to designate for trial any testimony coming out of the depositions."11 The Court will permit BYU to designate any testimony for trial and it will allow BYU to be present at the depositions and ask questions. Given the close proximity to trial in this case, however, the Court believes it will be difficult to allot equal time turning what may be a two day deposition into four days. But, the Court will leave it up to the parties to determine the best method for taking these depositions in a timely and efficient manner.
ORDER
For the reasons set forth above, Plaintiffs' Motion to Quash is DENIED.